 | Vol. 2.44 – 2 December, 2021 |
| |
|
|
| Scientists examined the microbial regulation of hexokinase 2 and its impact on inflammation using mice lacking hexokinase 2 in intestinal epithelial cells. [Cell Metabolism] |
|  |
|
|
PUBLICATIONSRanked by the impact factor of the journal |
|
|
|
| Researchers developed an organoid assembly approach starting with cells from the three primary germ layers—enteric neuroglial, mesenchymal, and epithelial precursors—that were derived separately from human PSCs. [Cell Stem Cell] |
|
|
|
| A functional dataset allowed improving mesoderm induction by ROCK inhibition, contained monogenetic and complex trait kidney disease genes, confirmed two additional congenital anomalies of the kidney and urinary tract genes, and provided a large candidate list of ciliopathy-related genes. [Cell Stem Cell] |
|
|
|
| A fabrication technique was developed to create a lymphangion-chip. This organ-on-chip consisted of co-culture of a monolayer of endothelial lumen surrounded by multiple and uniformly thick layers of muscle cells. [Lab On A Chip] |
|
|
|
| Investigators developed a microfluidic organ-on-chip platform for matrix-based, heterogeneous 3D cultures with fully integrated electrochemical chemo- and biosensor arrays for the energy metabolites oxygen, lactate, and glucose. [Lab On A Chip] |
|
|
|
| The authors investigated whether drug responses of organoids correlated with clinical responses of matched patients and disease progression of patients. [Molecular Oncology] |
|
|
|
| Investigators derived human proximal lung organoids from patient-derived PSCs carrying disease-causing cystic fibrosis transmembrane conductance regulator mutations. [Molecular Therapy-Methods & Clinical Development] |
|
|
|
| To address limitations in cell culture and in vivo mechanotransductive models, scientists developed two mouse lung organoid mechanotransductive models using postnatal day five mouse lung CD326-positive cells and fibroblasts subjected to increased, decreased, and cyclic strain. [American Journal of Physiology-Lung Cellular and Molecular Physiology] |
|
|
|
| Researchers examined tumor-infiltrating lymphocytes in colorectal cancer expressing different levels of SIRT1 and established a co-culture system with monocytes, CD8+ T cells and patient-derived tumor organoids to study the relationships between immune cells and cancer cells. [Cellular Immunology] |
|
|
|
|
| In serum-free medium, rosiglitazone, a peroxisome proliferator activator receptor-γ agonist, was reported to induce immortalised human meibomian gland epithelia cell differentiation, neutral lipid accumulation and expression of key biomarkers of differentiation. [Ocular Surface] |
|
|
|
| Scientists review the most recent advances in modeling Alzheimer’s disease in organoids and other engineered 3D cell culture systems. [Current Opinion in Neurobiology] |
|
|
|
|
| Chinook Therapeutics, Inc. announced the formation of SanReno Therapeutics, a joint venture with an investor syndicate led by Frazier Healthcare Partners and Pivotal bioVenture Partners China, to develop, manufacture and commercialize kidney disease therapies. [Chinook Therapeutics, Inc.] |
|
|
|
| The National Cancer Institute has awarded Mount Sinai researchers $3.15 million in grant funding to assess the potential of a multidisciplinary drug development platform to identify new biological targets for precision-based therapeutics for hepatocellular carcinoma. [Mount SInai] |
|
|
|
|
| January 16 – 20, 2022 Banff, Alberta, Canada |
|
|
|
|
|
| KU Leuven – Leuven, Belgium |
|
|
|
| Accession Therapeutics – Oxford, England, United Kingdom |
|
|
|
|
| Harvard Joslin Diabetes Center – Boston, Massachusetts, United States |
|
|
|
| Emory University – Atlanta, Georgia, United States |
|
|
|
|